 |
BEIJING, China, Aug. 5, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series D financing round. The announcement was made at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial Park, a key hub for Beijing's life sciences sector.
Financing Co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund
The Series D round was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund. The new capital will be used to accelerate METiS' core strategic initiatives, including automation upgrades to its proprietary platform, in-house pipeline development, expansion of global partnerships, and recruitment of world-class talent.
The Beijing Medical and Health Industry Investment Fund (Limited Partnership) is one of eight major industrial funds established with support from the Beijing Municipal Government. It focuses on innovative pharmaceuticals, advanced medical devices, and emerging technologies such as cell and gene therapy (CGT) and digital health. The fund plays a key role in accelerating the city's biotech innovation ecosystem.
Mr. REN Peng, Chairman and General Manager of Shunxi Management Co.,Ltd. commented: "Healthcare is a cornerstone of Beijing's innovation-driven strategy and a vital engine of emerging productivity. With the launch of the city's AI+Healthcare Innovation Action Plan, Beijing is strategically integrating AI with life sciences to lead the next phase of high-quality growth. Our RMB 20 billion fund reflects our commitment to advancing innovation in CGT. METiS fills a critical gap in advanced formulation and delivery systems, and we believe their technology will set new standards in AI-powered nanodelivery."
Mr. LI Ming, Chairman of Beijing Daxing District Investment Group Co., Ltd., added:
"Daxing District is committed to making biopharma a core pillar of its economic growth strategy. The launch of the OpenCGT platform marks a major milestone that will accelerate the commercialization of cutting-edge technologies, while attracting top global talent, capital, and innovation to Daxing - enhancing our competitiveness in CGT on the world stage."
Mr. HUANG Hantao, Deputy General Manager of CICC Capital, noted:
"We are grateful for the strong support from Beijing's leadership, Shunxi Management, and Daxing District across policy, capital, talent, and infrastructure. METiS has made tremendous progress over the past two years. As a long-term investor, CICC Capital will continue to support the company in R&D collaborations with our portfolio companies, clinical development, talent acquisition, and capital markets—empowering the next wave of breakthroughs in AI-enabled drug delivery."
Dr. Chris LAI, Co-founder and CEO of METiS Technologies, stated:
"We are deeply grateful for the trust and support from the Beijing municipal government, our investors, and our ecosystem partners. Solving the grand challenge of nanodelivery through AI innovation is not just METiS' mission—it's our commitment to the broader life sciences ecosystem. We will continue to develop homegrown, world-class delivery technologies to support the high-quality growth of China's CGT industry."
METiS Technologies Becomes a Pillar Enterprise of Beijing's OpenCGT Platform
CGT represents the third major wave of pharmaceutical innovation, following small molecules and biologics. In 2024, five Beijing authorities—including the Municipal Science and Technology Commission and Zhongguancun Administrative Committee—jointly launched a Three-Year Action Plan aimed at accelerating CGT development. The plan sets out to foster over 20 cutting-edge CGT companies by 2027 and establish a globally recognized CGT innovation cluster.
As a cornerstone of this initiative, METiS launched the OpenCGT platform—designed to address key challenges in precision nanodelivery, reduce costs and complexity, and enable the clinical translation of next-generation CGT therapies. This platform is set to become a new engine driving Beijing's life sciences growth.
Leveraging METiS' proprietary AI nanodelivery technology, the OpenCGT platform bridges the gap between foundational research in leading academic institutions and major hospitals, and translational work by biotech firms. Its inaugural project is to enable AccurEdit Therapeutics to develop a liver-targeted CRISPR gene-editing therapy using mRNA-LNP delivery.
AccurEdit Therapeutics is a pioneering biotech company developing precise, safe, and effective in vivo gene editing therapies for hereditary and acquired diseases. The company has built a best-in-class, end-to-end platform for in vivo gene editing that integrates RNA synthesis, editing, and delivery technologies. In October 2023, AccurEdit became the first and only company in China to demonstrate systemic CRISPR gene editing in humans with confirmed safety and efficacy.
About METiS Technologies
Unlocking a healthier world through AI-driven nanotechnology. METiS Technologies is a pioneering TechBio company at the intersection of artificial intelligence and nanomaterial science, focused on transforming the delivery and application of active agents across life forms.
Founded by a team of MIT-trained scientists with deep expertise in AI, quantum mechanics, nanomaterials, and advanced drug delivery, the company has developed three proprietary platform technologies, AiLNP – AI platform for nucleic acid delivery system design; AiRNA – AI platform for mRNA sequence optimization; and AiTEM – AI platform for small molecule formulation design.
METiS' platforms simulate, predict, and interpret nanoscale interactions to enable rational design, optimization, and validation of next-generation nanomaterials and their payloads. By advancing AI-enabled nanotechnology, METiS strives to unlock new therapeutic possibilities across a wide range of diseases, including cancer, metabolic and autoimmune disorders, and neurodegenerative conditions, and improve the health of lives.
BEIJING, China, Aug. 5, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series D financing round. The announcement was made at the Zhongguancun (Daxing) Cell and Gene Therapy Industrial Park, a key hub for Beijing's life sciences sector.
Financing Co-led by Beijing Medical and Health Industry Investment Fund and Daxing Industrial Investment Fund
The Series D round was co-led by the Beijing Medical and Health Industry Investment Fund and the Daxing Industrial Investment Fund. The new capital will be used to accelerate METiS' core strategic initiatives, including automation upgrades to its proprietary platform, in-house pipeline development, expansion of global partnerships, and recruitment of world-class talent.
The Beijing Medical and Health Industry Investment Fund (Limited Partnership) is one of eight major industrial funds established with support from the Beijing Municipal Government. It focuses on innovative pharmaceuticals, advanced medical devices, and emerging technologies such as cell and gene therapy (CGT) and digital health. The fund plays a key role in accelerating the city's biotech innovation ecosystem.
Mr. REN Peng, Chairman and General Manager of Shunxi Management Co.,Ltd. commented: "Healthcare is a cornerstone of Beijing's innovation-driven strategy and a vital engine of emerging productivity. With the launch of the city's AI+Healthcare Innovation Action Plan, Beijing is strategically integrating AI with life sciences to lead the next phase of high-quality growth. Our RMB 20 billion fund reflects our commitment to advancing innovation in CGT. METiS fills a critical gap in advanced formulation and delivery systems, and we believe their technology will set new standards in AI-powered nanodelivery."
Mr. LI Ming, Chairman of Beijing Daxing District Investment Group Co., Ltd., added:
"Daxing District is committed to making biopharma a core pillar of its economic growth strategy. The launch of the OpenCGT platform marks a major milestone that will accelerate the commercialization of cutting-edge technologies, while attracting top global talent, capital, and innovation to Daxing - enhancing our competitiveness in CGT on the world stage."
Mr. HUANG Hantao, Deputy General Manager of CICC Capital, noted:
"We are grateful for the strong support from Beijing's leadership, Shunxi Management, and Daxing District across policy, capital, talent, and infrastructure. METiS has made tremendous progress over the past two years. As a long-term investor, CICC Capital will continue to support the company in R&D collaborations with our portfolio companies, clinical development, talent acquisition, and capital markets—empowering the next wave of breakthroughs in AI-enabled drug delivery."
Dr. Chris LAI, Co-founder and CEO of METiS Technologies, stated:
"We are deeply grateful for the trust and support from the Beijing municipal government, our investors, and our ecosystem partners. Solving the grand challenge of nanodelivery through AI innovation is not just METiS' mission—it's our commitment to the broader life sciences ecosystem. We will continue to develop homegrown, world-class delivery technologies to support the high-quality growth of China's CGT industry."
METiS Technologies Becomes a Pillar Enterprise of Beijing's OpenCGT Platform
CGT represents the third major wave of pharmaceutical innovation, following small molecules and biologics. In 2024, five Beijing authorities—including the Municipal Science and Technology Commission and Zhongguancun Administrative Committee—jointly launched a Three-Year Action Plan aimed at accelerating CGT development. The plan sets out to foster over 20 cutting-edge CGT companies by 2027 and establish a globally recognized CGT innovation cluster.
As a cornerstone of this initiative, METiS launched the OpenCGT platform—designed to address key challenges in precision nanodelivery, reduce costs and complexity, and enable the clinical translation of next-generation CGT therapies. This platform is set to become a new engine driving Beijing's life sciences growth.
Leveraging METiS' proprietary AI nanodelivery technology, the OpenCGT platform bridges the gap between foundational research in leading academic institutions and major hospitals, and translational work by biotech firms. Its inaugural project is to enable AccurEdit Therapeutics to develop a liver-targeted CRISPR gene-editing therapy using mRNA-LNP delivery.
AccurEdit Therapeutics is a pioneering biotech company developing precise, safe, and effective in vivo gene editing therapies for hereditary and acquired diseases. The company has built a best-in-class, end-to-end platform for in vivo gene editing that integrates RNA synthesis, editing, and delivery technologies. In October 2023, AccurEdit became the first and only company in China to demonstrate systemic CRISPR gene editing in humans with confirmed safety and efficacy.
About METiS Technologies
Unlocking a healthier world through AI-driven nanotechnology. METiS Technologies is a pioneering TechBio company at the intersection of artificial intelligence and nanomaterial science, focused on transforming the delivery and application of active agents across life forms.
Founded by a team of MIT-trained scientists with deep expertise in AI, quantum mechanics, nanomaterials, and advanced drug delivery, the company has developed three proprietary platform technologies, AiLNP – AI platform for nucleic acid delivery system design; AiRNA – AI platform for mRNA sequence optimization; and AiTEM – AI platform for small molecule formulation design.
METiS' platforms simulate, predict, and interpret nanoscale interactions to enable rational design, optimization, and validation of next-generation nanomaterials and their payloads. By advancing AI-enabled nanotechnology, METiS strives to unlock new therapeutic possibilities across a wide range of diseases, including cancer, metabolic and autoimmune disorders, and neurodegenerative conditions, and improve the health of lives.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing's Biopharmaceutical Innovation Engine
|
All On-site Profits Donated to Fund Tai Po Fire Recovery Efforts
HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Tam Jai International Co. Limited ("TJI") has concluded its debut as the official partner of Clockenflap 2025, uniting its three renowned rice noodle brands – TamJai Yunnan Mixian, TamJai SamGor Mixian and the international brand TamJai Mixian – for the first time. The collaboration brought the "Made in Hong Kong, Made to Move" spirit to the Central Harbourfront. In light of the recent tragedy in Tai Po, TJI remained guided by its genuine "Passion to Serve", pledging all on-site profits from the festival to the Tung Wah Group of Hospitals to fund recovery efforts and support for residents in need.
Throughout the weekend, the trio brands welcomed music fans on a culinary journey that embodied the brands' dedication to the city. The activation served as a global stage to showcase TamJai and SamGor's Hong Kong-born legacy while demonstrating how TamJai Mixian unifies the best of both brands for international expansion.
- "Made in Hong Kong" was highlighted to celebrate bold flavours, distinctive style and a lively dining vibe, all originated in Hong Kong and brought to life through Tam Jai's craftsmanship, signature soups and the iconic 10 spice levels honed over the years.
- "Made to Move" symbolised the relentless drive to innovate, expand into new markets and champion noodle culture on the global stage, sharing the unique "Tam Jai Taste" with the world.
Music fans immersed themselves in rhythm and delight to taste buds at the "TamJai Avenue", a dedicated zone decked in signature TamJai green and SamGor red to create a space that felt both nostalgic and fresh. Every corner was infused with the identities of the three brands, allowing visitors to explore installations that blended rice noodle heritage with Hong Kong culture.
Mr Daren Lau, Chairman and Chief Executive Officer of TJI, reflected on the event, "'Bringing the unique Tam Jai Taste to the world' has never been merely a statement, but a commitment and vision that we have built step by step throughout the years. From our deep origins in this vibrant city, we have cultivated three iconic brands – 'TamJai Yunnan Mixian', 'TamJai SamGor Mixian' and 'TamJai Mixian'. Their debut on a united front at Clockenflap symbolises an important step in our journey to present Hong Kong's spirit on a global stage, sharing our beloved 'Tam Jai Taste' with music enthusiasts across the globe."
"Music has the power to connect, heal and uplift, especially in challenging times. With deep love for the families affected by the tragic Tai Po fire, TJI donates all profits from Clockenflap 2025 to support the emergency needs and recovery efforts of the community. This reflects our 'Passion to Serve' brand DNA, bringing warmth, care and hope to the communities we proudly call home."
A Culinary Recap: The Taste of Hong Kong
Festival-goers gathered at "The Taste of Hong Kong" dining area to experience an East-meets-West menu created exclusively for the event.
While fans enjoyed reimagined classics like the Mini Mixian with Pork Belly in Mala Soup, the standout items of the weekend included the innovative "Minced Pork and Homemade Pickle" series. The Minced Pork and Homemade Pickles Mini Burger and the fusion-style Avocado in Garlic and Chilli Sauce were among the most popular choices, demonstrating how authentic mixian ingredients can be transformed into shareable festival snacks.
Local Craftsmanship: Spiced Mixology
The "Spiced Mixology" Bar, a partnership with local craft distiller Perfume Trees Gin, offered cocktails that captured the essence of Hong Kong. With unique and distinctive flavours, both drinks sold out quickly on each event day and became one of the most sought-after highlights of the music festival.
- Spicy Banger (Left): A crisp gin base sharpened by SamGor's signature spice, lychee and lemongrass, finished with a facing heaven chilli.
- Gin'ger (Right): A refreshing mix of TamJai's soup essence, whiskey and gin, balanced with warming ginger and a crisp cucumber garnish.
Interactive Highlights: Engaging with the Brand
Beyond the culinary offerings, "TamJai Avenue" provided immersive cultural experiences. The "Make Your Own Bowl" workshop saw hundreds of fans creating customised phone straps featuring ingredient-shaped charms. Meanwhile, the "Spicy Soup Master" activation invited participants to roll a giant dice, with those braving the "Extremely Spicy" level receiving exclusive memorabilia. The "Bring TamJai Home" collection, featuring "Tastebud Troopers" plush toys and "Spicy Monster Gang" figurines, also proved to be a popular memento of the festival.
Looking Ahead: A Milestone Year in 2026
Following the conclusion of Clockenflap, TJI is looking towards a significant year ahead. 2026 marks the 30th Anniversary of TamJai Yunnan Mixian, a milestone celebrating three decades of serving Hong Kong. Furthermore, TamJai SamGor Mixian is preparing to take its unique flavours to new heights. Fans can look forward to a new store situated where the city connects with the world, offering one last taste of home before your next adventure. For those always on the move, you can savour the authentic taste of Tam Jai across Mainland China, Australia, Malaysia, Singapore and Japan.
About Us
Tam Jai International Co. Limited is one of the leading restaurant groups in Hong Kong, rapidly expanding its network to over 240 stores across various markets, including Mainland China, Singapore, Japan, Australia and Malaysia, with plans to enter the Philippines. Apart from self-operating restaurants, the Group also adopts alternative models such as joint venture, franchise or strategic partnership for overseas markets. The Group's portfolio of distinguished brands includes TamJai Yunnan Mixian, TamJai SamGor Mixian, and international brand TamJai Mixian, as well as Japanese dining brands, Marugame Seimen and Yakiniku Yamagyu, through franchise and licensing in Hong Kong.
With highly standardised operations, an innovative spirit and an efficient management model, TJI is committed to providing customers with a quality yet affordable dining experience while ambitiously expanding its footprints across the globe.
TamJai Yunnan Mixian brand is a fast casual restaurant chain in Hong Kong with operations in Mainland China. Our brand has over 30 years of history and the first restaurant under the TamJai Yunnan Mixian brand in Hong Kong was opened in 1996. In 2021, we opened our first restaurant under our brand in Mainland China.
TamJai SamGor Mixian brand is a fast casual restaurant chain in Hong Kong with operations in Singapore. Our brand has over 17 years of history and the first restaurant under the TamJai SamGor Mixian brand in Hong Kong was opened in 2008. In 2020 and 2022, we opened our first restaurant under our brand in Singapore and Japan respectively.
TamJai Mixian represents our international brand, capturing the essence of our flagship brands "TamJai Yunnan Mixian" and "TamJai SamGor Mixian" in Hong Kong. We launched our first store under this brand in Melbourne, Australia, in November 2024. Our stores in Mainland China were also revamped into "TamJai Mixian" starting from 2024. In July 2025, we opened our first restaurant in Malaysia.
All On-site Profits Donated to Fund Tai Po Fire Recovery Efforts
HONG KONG, Jan. 16, 2026 /PRNewswire/ -- Tam Jai International Co. Limited ("TJI") has concluded its debut as the official partner of Clockenflap 2025, uniting its three renowned rice noodle brands – TamJai Yunnan Mixian, TamJai SamGor Mixian and the international brand TamJai Mixian – for the first time. The collaboration brought the "Made in Hong Kong, Made to Move" spirit to the Central Harbourfront. In light of the recent tragedy in Tai Po, TJI remained guided by its genuine "Passion to Serve", pledging all on-site profits from the festival to the Tung Wah Group of Hospitals to fund recovery efforts and support for residents in need.
Throughout the weekend, the trio brands welcomed music fans on a culinary journey that embodied the brands' dedication to the city. The activation served as a global stage to showcase TamJai and SamGor's Hong Kong-born legacy while demonstrating how TamJai Mixian unifies the best of both brands for international expansion.
- "Made in Hong Kong" was highlighted to celebrate bold flavours, distinctive style and a lively dining vibe, all originated in Hong Kong and brought to life through Tam Jai's craftsmanship, signature soups and the iconic 10 spice levels honed over the years.
- "Made to Move" symbolised the relentless drive to innovate, expand into new markets and champion noodle culture on the global stage, sharing the unique "Tam Jai Taste" with the world.
Music fans immersed themselves in rhythm and delight to taste buds at the "TamJai Avenue", a dedicated zone decked in signature TamJai green and SamGor red to create a space that felt both nostalgic and fresh. Every corner was infused with the identities of the three brands, allowing visitors to explore installations that blended rice noodle heritage with Hong Kong culture.
Mr Daren Lau, Chairman and Chief Executive Officer of TJI, reflected on the event, "'Bringing the unique Tam Jai Taste to the world' has never been merely a statement, but a commitment and vision that we have built step by step throughout the years. From our deep origins in this vibrant city, we have cultivated three iconic brands – 'TamJai Yunnan Mixian', 'TamJai SamGor Mixian' and 'TamJai Mixian'. Their debut on a united front at Clockenflap symbolises an important step in our journey to present Hong Kong's spirit on a global stage, sharing our beloved 'Tam Jai Taste' with music enthusiasts across the globe."
"Music has the power to connect, heal and uplift, especially in challenging times. With deep love for the families affected by the tragic Tai Po fire, TJI donates all profits from Clockenflap 2025 to support the emergency needs and recovery efforts of the community. This reflects our 'Passion to Serve' brand DNA, bringing warmth, care and hope to the communities we proudly call home."
A Culinary Recap: The Taste of Hong Kong
Festival-goers gathered at "The Taste of Hong Kong" dining area to experience an East-meets-West menu created exclusively for the event.
While fans enjoyed reimagined classics like the Mini Mixian with Pork Belly in Mala Soup, the standout items of the weekend included the innovative "Minced Pork and Homemade Pickle" series. The Minced Pork and Homemade Pickles Mini Burger and the fusion-style Avocado in Garlic and Chilli Sauce were among the most popular choices, demonstrating how authentic mixian ingredients can be transformed into shareable festival snacks.
Local Craftsmanship: Spiced Mixology
The "Spiced Mixology" Bar, a partnership with local craft distiller Perfume Trees Gin, offered cocktails that captured the essence of Hong Kong. With unique and distinctive flavours, both drinks sold out quickly on each event day and became one of the most sought-after highlights of the music festival.
- Spicy Banger (Left): A crisp gin base sharpened by SamGor's signature spice, lychee and lemongrass, finished with a facing heaven chilli.
- Gin'ger (Right): A refreshing mix of TamJai's soup essence, whiskey and gin, balanced with warming ginger and a crisp cucumber garnish.
Interactive Highlights: Engaging with the Brand
Beyond the culinary offerings, "TamJai Avenue" provided immersive cultural experiences. The "Make Your Own Bowl" workshop saw hundreds of fans creating customised phone straps featuring ingredient-shaped charms. Meanwhile, the "Spicy Soup Master" activation invited participants to roll a giant dice, with those braving the "Extremely Spicy" level receiving exclusive memorabilia. The "Bring TamJai Home" collection, featuring "Tastebud Troopers" plush toys and "Spicy Monster Gang" figurines, also proved to be a popular memento of the festival.
Looking Ahead: A Milestone Year in 2026
Following the conclusion of Clockenflap, TJI is looking towards a significant year ahead. 2026 marks the 30th Anniversary of TamJai Yunnan Mixian, a milestone celebrating three decades of serving Hong Kong. Furthermore, TamJai SamGor Mixian is preparing to take its unique flavours to new heights. Fans can look forward to a new store situated where the city connects with the world, offering one last taste of home before your next adventure. For those always on the move, you can savour the authentic taste of Tam Jai across Mainland China, Australia, Malaysia, Singapore and Japan.
About Us
Tam Jai International Co. Limited is one of the leading restaurant groups in Hong Kong, rapidly expanding its network to over 240 stores across various markets, including Mainland China, Singapore, Japan, Australia and Malaysia, with plans to enter the Philippines. Apart from self-operating restaurants, the Group also adopts alternative models such as joint venture, franchise or strategic partnership for overseas markets. The Group's portfolio of distinguished brands includes TamJai Yunnan Mixian, TamJai SamGor Mixian, and international brand TamJai Mixian, as well as Japanese dining brands, Marugame Seimen and Yakiniku Yamagyu, through franchise and licensing in Hong Kong.
With highly standardised operations, an innovative spirit and an efficient management model, TJI is committed to providing customers with a quality yet affordable dining experience while ambitiously expanding its footprints across the globe.
TamJai Yunnan Mixian brand is a fast casual restaurant chain in Hong Kong with operations in Mainland China. Our brand has over 30 years of history and the first restaurant under the TamJai Yunnan Mixian brand in Hong Kong was opened in 1996. In 2021, we opened our first restaurant under our brand in Mainland China.
TamJai SamGor Mixian brand is a fast casual restaurant chain in Hong Kong with operations in Singapore. Our brand has over 17 years of history and the first restaurant under the TamJai SamGor Mixian brand in Hong Kong was opened in 2008. In 2020 and 2022, we opened our first restaurant under our brand in Singapore and Japan respectively.
TamJai Mixian represents our international brand, capturing the essence of our flagship brands "TamJai Yunnan Mixian" and "TamJai SamGor Mixian" in Hong Kong. We launched our first store under this brand in Melbourne, Australia, in November 2024. Our stores in Mainland China were also revamped into "TamJai Mixian" starting from 2024. In July 2025, we opened our first restaurant in Malaysia.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
Tam Jai International Unites Its Three Iconic Brands at Clockenflap 2025, Rallies Support for Tai Po Community with "Made in Hong Kong, Made to Move" Spirit
